- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02109757
Evaluation of Hearing Protection Fit Testing Program
April 7, 2014 updated by: Quintin Hecht, United States Air Force
The specific aim of this research is to evaluate the performance, effectiveness, and long-term training benefits of a formal hearing protection fit testing program.
This study may provide preliminary evidence on the benefits of direct education/training combined with a formal hearing protection device (HPD) fit testing on HPD fittings on United States Air Force (USAF) employees.
Currently, Public Health provides informal, subjective training to employees; this practice may be altered by the results of this study.
Study Overview
Status
Unknown
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Anticipated)
200
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alaska
-
Elemendorf Air Force Base, Alaska, United States
- Recruiting
- Elmendorf Air Force Base
-
Contact:
- Shannon Hunt, Au.D.
- Phone Number: 907-580-5804
- Email: shannon.hunt.3@us.af.mil
-
Principal Investigator:
- Shannon Hunt, Au.D.
-
Sub-Investigator:
- Daniel Williams, Au.D.
-
-
Ohio
-
Dayton, Ohio, United States, 45433
- Recruiting
- Wright-Patterson Air Force Base
-
Contact:
- Quintin A Hecht, Au.D.
- Phone Number: 937-938-3201
- Email: quintin.hecht.1@us.af.mil
-
Principal Investigator:
- Quintin A Hecht, Au.D.
-
Sub-Investigator:
- Elizabeth A McKenna, Au.D.
-
Sub-Investigator:
- April Taylor, Au.D.
-
Sub-Investigator:
- Malisha Martukovich, Au.D.
-
Sub-Investigator:
- Matthew Williams, Au.D.
-
Sub-Investigator:
- Katie Tastad, MPH
-
Sub-Investigator:
- Christina Waldrop, Associates
-
Sub-Investigator:
- Michelle LeMond, Associates
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subjects must be enrolled in the hearing conservation program, and can be civilian or active duty/uniformed. Subjects must be currently using some form of in-the-ear hearing protection device on a regular basis and have ear canals free of cerumen, infection, or any other obstruction.
Exclusion Criteria:
- Not enrolled in the hearing conservation program. Not using in-the-ear hearing protection device on a regular basis. Ear canals containing cerumen, infection, or other obstructions.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Software intervention and education
This group will receive software intervention and education before and after receiving one-on-one education, thus showing if benefit or effect occurs simply due to having the software input before receiving education.
|
Personal attenuation rating measurements will be taken before and after educating the patient using software program
|
Active Comparator: Education only
This group will not receive software intervention prior to and after one-on-one education, only afterwards.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Degree of earplug fit for participants in the Air Force Hearing Conservation Program as a measure of education and personnal attenuation rating.
Time Frame: 6 mos after intial subject visit
|
The experimental group will show an increase, larger than the control group, in the amount of personal attenuation rating measurement shown by the software program as a result of software intervention used before and after education at the initial and follow-up visits.
|
6 mos after intial subject visit
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Quintin A Hecht, Au.D., United States Air Force School of Aerospace Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2014
Primary Completion (Anticipated)
October 1, 2015
Study Registration Dates
First Submitted
January 9, 2014
First Submitted That Met QC Criteria
April 7, 2014
First Posted (Estimate)
April 10, 2014
Study Record Updates
Last Update Posted (Estimate)
April 10, 2014
Last Update Submitted That Met QC Criteria
April 7, 2014
Last Verified
April 1, 2014
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- FWR20130114H
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hearing Loss
-
University of California, San FranciscoPatient-Centered Outcomes Research InstituteRecruitingHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Noise-Induced | Hearing Loss, Unilateral | Hearing Loss, Mixed | Hearing Disorders in ChildrenUnited States
-
Oticon MedicalRecruitingEar Diseases | Hearing Loss, Conductive | Hearing Loss Mixed | Hearing Disability | Conductive Hearing Loss | Conductive Hearing Loss, Bilateral | Conductive Hearing Loss, UnilateralUnited Kingdom
-
MED-EL Elektromedizinische Geräte GesmbHCompletedHearing Loss | Hearing Loss, Sensorineural | Hearing Loss, Bilateral | Hearing Loss, Conductive | Hearing Loss, Unilateral | Hearing Loss, MixedAustria, Germany, United Kingdom
-
Oticon MedicalNot yet recruitingSensorineural Hearing Loss, Bilateral | Sensorineural Hearing Loss, Severe | Sensorineural Hearing Loss, Profound
-
Manchester University NHS Foundation TrustUniversity of ManchesterCompletedCochlear Hearing Loss | Sensorineural Hearing Loss, BilateralUnited Kingdom
-
Oticon MedicalCompletedConductive Hearing Loss | Conductive and Sensori-neural Hearing Loss in the Same Ear | Unilateral, Profound Sensori-neural Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Presbycusis | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
-
Otologic Pharmaceutics, Inc.CompletedHearing Loss | Sensorineural Hearing Loss | Noise-Induced Hearing LossUnited States
-
Frequency TherapeuticsCompletedHearing Loss, Sensorineural | Noise Induced Hearing Loss | Sudden Hearing LossUnited States
Clinical Trials on Software intervention and education
-
Agency for Healthcare Research and Quality (AHRQ)Unknown
-
Universidad del DesarrolloCompletedVirtual Reality | Social StigmaChile
-
Adai Technology (Beijing) Co., Ltd.Not yet recruiting
-
Washington University School of MedicineSt. Jude Children's Research HospitalCompletedChildhood Cancer | Pediatric Cancer | Cardiac ToxicityUnited States
-
Thomas Jefferson UniversityNot yet recruitingMetastatic Prostate Carcinoma | Stage IV Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8United States
-
Chang Gung Memorial HospitalRecruitingAcute Decompensated Heart FailureTaiwan
-
Children's Oncology GroupNational Cancer Institute (NCI); Yale UniversityActive, not recruitingHematopoietic and Lymphoid Cell Neoplasm | Malignant Solid NeoplasmUnited States, Canada
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI); National Institute on Minority Health and...RecruitingHuman Papillomavirus InfectionUnited States
-
Chengdu Jinjiang Maternity and Child Health HospitalNot yet recruiting
-
Ohio State University Comprehensive Cancer CenterRecruitingMalignant Solid Neoplasm | Hematopoietic and Lymphoid System NeoplasmUnited States